Results 301 to 310 of about 3,281,120 (365)

Incident users of antipsychotic agents and future use of cholesterol-lowering drugs: an observational, pharmacoepidemiologic study.

Journal of Clinical Psychiatry, 2015
OBJECTIVE Antipsychotic agents have serious metabolic adverse effects, among them dyslipidemia, which may necessitate secondary prophylaxis with cholesterol-lowering drugs.
S. Skrede, I. F. Tvete, L. Tanum, V. Steen, J. Bramness   +4 more
semanticscholar   +1 more source

Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.

Bipolar Disorders, 2014
OBJECTIVE An emerging body of evidence supports a role for dysfunctional purinergic neurotransmission in mood disorders. Adenosine agonists have been shown to have properties similar to those of dopamine antagonists; there is a well-characterized ...
M. Weiser, S. Burshtein, A. Gershon, G. Marian, N. Vlad, I. G. Grecu, E. Tocari, A. Tiugan, M. Hotineanu, John M. Davis   +9 more
semanticscholar   +1 more source

Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?

Future Medicinal Chemistry, 2014
The introduction of typical antipsychotics over six decades ago signaled an important milestone in psychiatry. However, second-generation antipsychotics ameliorated the positive symptoms of schizophrenia but displayed limited effectiveness for the ...
P. Zajdel, A. Partyka, Krzysztof Marciniec, A. Bojarski, M. Pawłowski, A. Wesołowska   +5 more
semanticscholar   +1 more source

Antipsychotic Agents in Patients with Dementia

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
We conducted a MEDLINE search to obtain data on various antipsychotics administered to patients with dementia and psychosis or behavioral symptoms. Additional unpublished data from conference proceedings and unpublished clinical trials were provided by Janssen Pharmaceutica, Eli Lilly and Company, and Zeneca Pharmaceuticals.
M. Lynn Crismon, Jennifer L. Defilippi
openaire   +3 more sources

Antidepressant and antipsychotic agents

Naturwissenschaften, 1979
Numerous studies have been reviewed concerning the relationship of the catecholamines and indoleamines to depression and its treatment with antidepressant drugs. The profusion of data on the subject suggests the amines may be implicated in the disease, however no convincing hypothesis is available which unites the two.
openaire   +3 more sources

Adverse Effects of Antipsychotic Agents

Drugs, 1981
Neumleptics produce many adverse effects. While some of these are of little import beyond being a nuisance, others are both unusual and potentially serious. Since no consistent reporting mechanism has been established, the exact incidence and severity are often unclear.
George M. Simpson, Edmond H. Pi, John J. Sramek   +2 more
openaire   +3 more sources

Galactorrhea and Antipsychotic Agents

JAMA: The Journal of the American Medical Association, 1976
To the Editor.— In reading LETTERS TO THE EDITOR (234:913, 1975), I was most surprised at the comments of Drs Masco and Leis concerning galactorrhea and antipsychotic agents. The wish of a physician to avoid galactorrhea in a patient requiring an antipsychotic agent is perfectly reasonable from the clinical point of view.
openaire   +3 more sources

Galactorrhea and Antipsychotic Agents

JAMA: The Journal of the American Medical Association, 1975
To the Editor.— In reading through your QUESTION AND ANSWER (232:962, 1975), I was somewhat disturbed to come across a letter requesting information about persistent bilateral galactorrhea in a patient who was receiving thioridazine, 100 mg twice a day, and amitriptyline hydrochloride, 10 mg twice a day. The disturbing statements were actually in the
openaire   +3 more sources

Clozapine: A Novel Antipsychotic Agent

DICP, 1989
Clozapine is an antipsychotic without the extrapyramidal adverse effects associated with currently marketed antipsychotics. In animals, this drug has not been shown to induce catalepsy and only weakly antagonizes the stereotypic movements induced by apomorphine and the amphetamines.
Richard L. Wagner, Elena Bablenis, Stanley S. Weber   +2 more
openaire   +3 more sources

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

Psychiatric Services, 2010
OBJECTIVE This study examined off-label and evidence-based use of second-generation antipsychotic agents among elderly nursing home residents and factors associated with off-label use.
P. Kamble, J. Sherer, Hua Chen, R. Aparasu   +3 more
semanticscholar   +1 more source